These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

851 related articles for article (PubMed ID: 34342551)

  • 1. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
    Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
    Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of Na
    Primessnig U; Bracic T; Levijoki J; Otsomaa L; Pollesello P; Falcke M; Pieske B; Heinzel FR
    Eur J Heart Fail; 2019 Dec; 21(12):1543-1552. PubMed ID: 31762174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone-releasing hormone agonists ameliorate chronic kidney disease-induced heart failure with preserved ejection fraction.
    Rieger AC; Bagno LL; Salerno A; Florea V; Rodriguez J; Rosado M; Turner D; Dulce RA; Takeuchi LM; Kanashiro-Takeuchi RM; Buchwald P; Wanschel ACBA; Balkan W; Schulman IH; Schally AV; Hare JM
    Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33468654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction.
    Valero-Munoz M; Li S; Wilson RM; Boldbaatar B; Iglarz M; Sam F
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27810862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtotal nephrectomy accelerates pathological cardiac remodeling post-myocardial infarction: implications for cardiorenal syndrome.
    Liu S; Kompa AR; Kumfu S; Nishijima F; Kelly DJ; Krum H; Wang BH
    Int J Cardiol; 2013 Oct; 168(3):1866-80. PubMed ID: 23347614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
    Alex L; Russo I; Holoborodko V; Frangogiannis NG
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrochlorothiazide modulates ischemic heart failure-induced cardiac remodeling via inhibiting angiotensin II type 1 receptor pathway in rats.
    Luo J; Chen X; Luo C; Lu G; Peng L; Gao X; Zuo Z
    Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 28039944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telmisartan, a unique ARB, improves left ventricular remodeling of infarcted heart by activating PPAR gamma.
    Maejima Y; Okada H; Haraguchi G; Onai Y; Kosuge H; Suzuki J; Isobe M
    Lab Invest; 2011 Jun; 91(6):932-44. PubMed ID: 21403641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.
    Kosmala W; Holland DJ; Rojek A; Wright L; Przewlocka-Kosmala M; Marwick TH
    J Am Coll Cardiol; 2013 Oct; 62(15):1330-8. PubMed ID: 23916925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental cardiac radiation exposure induces ventricular diastolic dysfunction with preserved ejection fraction.
    Saiki H; Moulay G; Guenzel AJ; Liu W; Decklever TD; Classic KL; Pham L; Chen HH; Burnett JC; Russell SJ; Redfield MM
    Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H392-H407. PubMed ID: 28550173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection Fraction.
    Rieger AC; Tompkins BA; Natsumeda M; Florea V; Banerjee MN; Rodriguez J; Rosado M; Porras V; Valasaki K; Takeuchi LM; Collon K; Desai S; Bellio MA; Khan A; Kashikar ND; Landin AM; Hardin DV; Rodriguez DA; Balkan W; Hare JM; Schulman IH
    Stem Cells Transl Med; 2022 Mar; 11(1):59-72. PubMed ID: 35641169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dapagliflozin improves left ventricular remodeling and aorta sympathetic tone in a pig model of heart failure with preserved ejection fraction.
    Zhang N; Feng B; Ma X; Sun K; Xu G; Zhou Y
    Cardiovasc Diabetol; 2019 Aug; 18(1):107. PubMed ID: 31429767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canagliflozin Ameliorates Ventricular Remodeling through Apelin/Angiotensin-Converting Enzyme 2 Signaling in Heart Failure with Preserved Ejection Fraction Rats.
    Zhang T; Wang X; Wang Z; Zhai J; He L; Wang Y; Zuo Q; Ma S; Zhang G; Guo Y
    Pharmacology; 2023; 108(5):478-491. PubMed ID: 37611563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dipeptidyl peptidase-IV inhibitor improves diastolic dysfunction in Dahl salt-sensitive rats.
    Nakajima Y; Ito S; Asakura M; Min KD; Fu HY; Imazu M; Hitsumoto T; Takahama H; Shindo K; Fukuda H; Yamazaki S; Asanuma H; Kitakaze M
    J Mol Cell Cardiol; 2019 Apr; 129():257-265. PubMed ID: 30880253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Mineralocorticoid Receptor Antagonists on Cardiac Structure and Function in Patients With Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: A Meta-Analysis and Systematic Review.
    Pandey A; Garg S; Matulevicius SA; Shah AM; Garg J; Drazner MH; Amin A; Berry JD; Marwick TH; Marso SP; de Lemos JA; Kumbhani DJ
    J Am Heart Assoc; 2015 Oct; 4(10):e002137. PubMed ID: 26459931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction.
    Zhou L; Filiberti A; Humphrey MB; Fleming CD; Scherlag BJ; Po SS; Stavrakis S
    Exp Physiol; 2019 Jan; 104(1):28-38. PubMed ID: 30398289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor-2 With Oxidative Stress Inhibition.
    Liu Y; Liu Y; Liu X; Chen J; Zhang K; Huang F; Wang JF; Tang W; Huang H
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26109504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
    Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
    J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction.
    Salah EM; Bastacky SI; Jackson EK; Tofovic SP
    J Cardiovasc Pharmacol; 2018 Apr; 71(4):205-214. PubMed ID: 29620605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.